Skip to main content
← Companies
VNDA

Vanda Pharmaceuticals Inc.

Data as of Sep 17, 2026
VNDA
CIK 1347178Pharmaceutical Preparations

Lobbying

$0 in reported federal lobbying spend across 7 quarterly filings, most recently Jul 20, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.

Latest filings, Apr 2025 onward

FiledRegistrant and subjectAmount
Jul 20, 2026
MANATOS & MANATOS for VANDA PHARMACEUTICALS INC
Pharmacy FDA approval of specific medical drugs
$0
Apr 15, 2026
MANATOS & MANATOS for VANDA PHARMACEUTICALS INC
Pharmacy FDA approval of specific medical drugs
$0
Jan 8, 2026
MANATOS & MANATOS for VANDA PHARMACEUTICALS INC
Pharmacy FDA approval of specific medical drugs
$0
Oct 19, 2025
MANATOS & MANATOS for VANDA PHARMACEUTICALS INC
Pharmacy FDA approval of specific medical drugs
$0
Jul 16, 2025
MANATOS & MANATOS for VANDA PHARMACEUTICALS INC
Pharmacy FDA approval of specific medical drugs
$0
Apr 8, 2025
MANATOS & MANATOS for VANDA PHARMACEUTICALS INC
Pharmacy FDA approval of specific medical drugs
$0

Data: Quiver Quantitative, FEC, Senate Lobbying Disclosure Act filings, USAspending, congressional periodic transaction reports. Records are matched to Vanda Pharmaceuticals Inc. through its SEC registration (CIK 1347178) and tickers VNDA.

As of: lobbying filings through Jul 20, 2026; contract actions through Dec 12, 2025. Snapshot rebuilt Sep 17, 2026.

Holdings values are estimates from disclosed ranges. Donation coverage for a cycle begins with the first month loaded, so earlier months may still be missing.